Hi, this is Naomi. I’m off to Vienna for a diabetes conference, and I’ve come across a lesser-known GLP-1 side effect. More on that soon, but ...

A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

The pharmaceutical company that has become central to the Danish economy is readying to cut some 5,000 jobs in its home ...

The Danish drugmaker said a clinical trial showed participants who got a pill form of Wegovy lost an average of 16.6 percent ...

Novo Nordisk (NVO) has cemented itself as the leader in the booming weight-loss drug market with blockbuster treatments like ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies. Compare effectiveness and side effects here.

Novo Nordisk's Q2 2025 sales surge as Wegovy demand grows, driven by new obesity drug data. Click here to read an analysis of ...

It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

More than half of adults who used once-weekly semaglutide for obesity treatment discontinued the drug after less than 1 year, according to data presented at the European Association for the Study of ...

Novo Nordisk A/S (NVO) shares slid 3% in the early premarket session on Monday as the Ozempic and Wegovy weight-loss drugmaker snagged a bearish recommendation from a Wall Street firm. Morgan Stanley ...

Some people may be eligible for Medicare coverage for Wegovy if they meet medical criteria for heart disease risk. However, Medicare does not cover medications that are strictly for weight management.

The number of people who reported experiencing constant thoughts about food declined by 46% after starting treatment with ...